Breast implant-associated anaplastic large cell lymphoma: A comprehensive review

Antonio Marra(Memorial Sloan Kettering Cancer Center), Giuseppe Curigliano(European Institute of Oncology), Giulia Viale(Istituti di Ricovero e Cura a Carattere Scientifico), Francesca De Lorenzi(Istituti di Ricovero e Cura a Carattere Scientifico), Franco Nolè(European Institute of Oncology), Gabriella Pravettoni(University of Milan), Paolo Veronesi(Ripamonti), G. Viale(University of Milan), Stefano Pileri(European Institute of Oncology)
Cancer Treatment Reviews
January 13, 2020
10.1016/j.ctrv.2020.101963
Cited by 122

Related Papers

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k